What is/are Paromomycin?
Paromomycin is an aminoglycoside antibiotic, first isolated from Streptomyces krestomuceticus in the 1950s. It was discovered by Parke Davis now Pfizer and introduced as Humatin in 1960. It is also called monomycin and aminosidine;
It is an antibiotic used to treat intestinal infections such as cryptosporidiosis and amoebiasis, and other diseases like leishmaniasis. Paromomycin was demonstrated to be effective against cutaneous leishmaniasis in clinical studies in the USSR in the 1960s, and in trials with visceral leishmaniasis in the early 1990s
The route of administration is intramuscular injection and capsule. Paromomycin topical cream with or without gentamicin is an effective treatment for ulcerative cutaneous leishmaniasis, according to the results of a phase 3, randomized, double-blind, parallel group–controlled trial.
- An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
- Decreased hearing or ringing in the ears;
- Little or no urine production; or
Other less serious side effects may be more likely to occur. Continue to take paromomycin and talk to your doctor if you experience
- Nausea or vomiting;
- Diarrhea; or
Mechanism of action
Paromomycin is a protein synthesis inhibitor in non-resistant cells by binding to 16S ribosomal RNA. This broad spectrum antibiotic soluble in water, is very similar in action to Neomycin. Antimicrobial activity of Paromomycin against Escherichia coli and Staphylococcus aureus has been shown.
This article uses material from the Wikipedia article Paromomycin, which is released under the Creative Commons Attribution-Share-Alike License 3.0.